EODData

MEMBERSHIP REGISTER LOG IN

FRA, 9W8: IKONISYS EO 2

08 Apr 2026
LAST:

1.350

CHANGE:
 0.02		OPEN:
1.350		HIGH:
1.350		ASK:
0.000		VOLUME:
0
CHG(%):
1.50		PREV:
1.330		LOW:
1.350		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Apr 261.3501.3501.3501.3500
07 Apr 261.3301.3301.3301.3302.4K
02 Apr 261.3351.3351.3351.3350
01 Apr 261.3851.3851.3851.3850
31 Mar 261.3751.3751.3751.3750
30 Mar 261.3801.3801.3801.3800
27 Mar 261.4051.4051.4051.4050
26 Mar 261.4001.4001.4001.4002.4K
25 Mar 261.4201.4201.4201.4202.4K
24 Mar 261.4051.4051.4051.4052.4K

PROFILE

Name:IKONISYS EO 2
About:Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of gene rearrangements commonly associated with non-small cell lung carcinoma; oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene, which is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. In addition, it offers liquid biopsy/CTC bladder cancer detection and breast cancer early diagnostics products; CYTOfast vial solution for any type of cellular analysis; CYTOfast kit urine, a three day cytological urine test solution; CYTOfast PLUS, a liquid-phase processor that prepares thin-layer cytological samples from liquid-phase specimen; and Ikonisys intelligent application, a software designed to automatically quantify, qualify, and present cells for review. Ikonisys S.A. was incorporated in 2021 and is headquartered in Paris, France.
Sector:Healthcare
Address:62 rue de Caumartin, Paris, France, 75009
Website:https://ikonisys.com
ISIN:FR00140048X2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-5.42 
Forward P/E:65.79 
Price to Sales:17.38 
Price to Book:1.15 
Profit Margin:-1.94 
Operating Margin:-1.16 
Return on Assets:-0.06 
Return on Equity:-0.16 
Revenue:1.47M 
Shares:13.97M 
Market Cap:18.86M 

TECHNICAL INDICATORS

MA5:1.360.4%
MA10:1.382.1%
MA20:1.392.9%
MA50:1.479.0%
MA100:1.468.1%
MA200:1.468.0%
STO9:22.22
STO14:22.22
RSI14:41.67
WPR14:-77.78
MTM14:-0.05
ROC14:-0.04 
ATR:0.02 
Week High:1.392.6%
Week Low:1.331.5%
Month High:1.446.3%
Month Low:1.338.0%
Year High:1.6824.1%
Year Low:1.313.4%
Volatility:33.70